Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

PHASE2CompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

February 5, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

August 23, 2016

Conditions
2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer
Interventions
BIOLOGICAL

GVAX Pancreas Vaccine

BIOLOGICAL

CRS-207

DRUG

Chemotherapy

Investigator's choice of one of the following commercially available products: gemcitabine; capecitabine; fluorouracil with or without leucovorin; irinotecan; or erlotinib.

DRUG

cyclophosphamide

Trial Locations (21)

10029

Icahn School of Medicine at Mount Sinai, New York

10032

Columbia University Medical Center, New York

15232

University of Pittsburgh Medical Center Cancer Pavillion, Pittsburgh

21287

Johns Hopkins University, Baltimore

22908

University of Virginia Health System, Charlottesville

27710

Duke University Medical Center Morris Cancer Center, Durham

33136

University of Miami/Sylvester Cancer Center, Miami

37215

Vanderbilt University, Nashville

53792

University of Wisconsin - Carbone Cancer Center, Madison

55905

Mayo Clinic Rochester, Rochester

60637

University of Chicago Medical Center, Chicago

63110

Washington University, St Louis

77030

Baylor College of Medicine, Houston

80045

University of Colorado Denver, Aurora

85258

Scottsdale Healthcare Research Institute, Scottsdale

90404

University of California Los Angeles, Santa Monica

92037

University California San Diego Moores Cancer Center, La Jolla

94115

University of California Mt Zion Comprehensive Cancer Center, San Francisco

97213

Providence Cancer Center, Portland

98101

Virginia Mason Medical Center, Seattle

M5G 2M9

Princess Margaret Hospital Princess Margaret Cancer Center, Toronto

Sponsors
All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

Aduro Biotech, Inc.

INDUSTRY

NCT02004262 - Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting | Biotech Hunter | Biotech Hunter